Mo-BRUK (MBR) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
23 Jan, 2026Executive summary
H1 2024 consolidated revenue increased by 7.2% year-over-year, reaching PLN 120.2m, with over 86% from waste management, despite a half-year downtime at the Karsy incineration plant.
EBITDA and net profit declined significantly due to the Karsy plant downtime, El-Kajo integration, and higher investment outlays, with net profit at PLN 30.4m, down from PLN 40.6m in H1 2023.
Volumes processed rose from 116,000 to 150,000 tons, a 25% increase, and major investments, including Karsy plant modernization, have been completed.
El-Kajo's operational expenses were consolidated, with its positive EBITDA expected to contribute from Q3 2024.
Significant contracts signed, including a PLN 33m waste removal deal and a PLN 24.5m investment contract.
Financial highlights
H1 2024 consolidated turnover up 7.2% year-over-year; EBITDA for H1 2024 was PLN 44.3m, down from PLN 54.4m in H1 2023.
Net profit for H1 2024 was PLN 30.4m, down from PLN 40.6m in H1 2023.
Operating expenses increased by 22% year-over-year, mainly due to El-Kajo consolidation.
Q2 2024 core business profitability improved by 20% over Q1 2024.
RDF segment revenue up nearly 60%, with volume up 16%.
Outlook and guidance
Profitability is expected to improve in H2 2024 as the effects of Karsy plant modernization and El-Kajo integration become more visible.
Full operational capacity for all installations anticipated in 2025, with increased profitability and stability in the solidification and stabilization segment.
Ongoing investments aim to increase production capacity in waste stabilization and synthetic aggregate production.
New contracts and completed investments are expected to support future revenue growth.
No significant seasonality expected; business continuity is not at risk.
Latest events from Mo-BRUK
- Innovative recycling processes and legal wins drive growth in sustainable building materials.MBR
Investor presentation14 Jan 2026 - Revenue up 18% y/y, net profit down 10.6% as capacity and margins improve.MBR
Q3 202414 Jan 2026 - One-off write-down caused a net loss despite strong revenue and core business margins.MBR
Q3 20251 Dec 2025 - Record sales and EBITDA in 2024, with major investments boosting capacity and future growth.MBR
Q4 202414 Nov 2025 - Revenue and EBITDA rose in H1 2025, driven by medical waste and capacity expansion.MBR
Q2 202527 Aug 2025 - Revenue and EBITDA rose, but net profit fell amid higher costs and legal risks.MBR
Q1 20256 Jun 2025